Clinical trial
Seasonal Affective Depression (SAD) Study
NCT00069459 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00069459 |
|---|---|
| Title | Seasonal Affective Depression (SAD) Study |
| Official title | A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | Extended-release Bupropion Hydrochloride |
| Enrollment | 250 |
| Start date | Sep 23, 2003 |
| Primary completion | Jun 3, 2004 |
| Completion | Jun 3, 2004 |
| First posted | Sep 26, 2003 |
| Last update posted | Sep 25, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: